Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregnenolone for Depression and Substance Abuse
NCT00223197Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Feb 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pregnenolone in bipolar disorder (BD), major depressive disorder (MDD), substance use disorder (SUD), sponsored by UT Southwestern Medical Center. Started Feb 2004; status: completed.
02
Drugs
pregnenolone
03
Conditions
bipolar disorder (BD)major depressive disorder (MDD)substance use disorder (SUD)
Beyond the preview
Go deeper on NCT00223197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00223197.